{"id":15887,"date":"2026-06-04T05:53:00","date_gmt":"2026-06-04T03:53:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=ddf0ae0d7f99199983b7b47484e4c245"},"modified":"2026-06-04T05:53:00","modified_gmt":"2026-06-04T03:53:00","slug":"abvx-investors-have-opportunity-to-join-abivax-s-a-fraud-investigation-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=15887","title":{"rendered":"ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--$ABVX<\/a>--The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abivax S.A. (\u201cAbivax\u201d or \u201cthe Company\u201d) (NASDAQ: ABVX<\/a>) for violations of the securities laws.<\/p><\/a><\/a>

\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Abivax\u2019s Phase 3 ABTECT trial for obefazimod revealed rare malignancy cases as part of its results. Based on this news, shares of Abivax fell sharply on June 2, 2026.<\/p>

\nIf you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>

\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com<\/a>, or by email at bschall@schallfirm.com<\/a>.<\/p>

\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p> Contacts<\/b>

\nThe Schall Law Firm\nBrian Schall, Esq.\n310-301-3335\ninfo@schallfirm.com<\/a>www.schallfirm.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–$ABVX–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abivax S.A. (\u201cAbivax\u201d or \u201cthe Company\u201d) (NASDAQ: ABVX) for violations of the se…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15887","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15887"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15887\/revisions"}],"predecessor-version":[{"id":15888,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15887\/revisions\/15888"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}